Saroja Pharma Inds. Stock Price Analysis and Quick Research Report. Is Saroja Pharma Inds. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Saroja Pharma Inds.. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Saroja Pharma Inds. has a PE ratio of 7.7899811151973 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Saroja Pharma Inds. has ROA of 3.1285% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Saroja Pharma Inds. has a Current ratio of 1.2102.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Saroja Pharma Inds. has a ROE of 6.8225%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Saroja Pharma Inds. has a Debt to Equity ratio of 0.6032 which means that the company has low proportion of debt in its capital.

• Sales growth: Saroja Pharma Inds. has reported revenue growth of 32.1065% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Saroja Pharma Inds. for the current financial year is 5.18884430116815%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Saroja Pharma Inds. is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Saroja Pharma Inds. is Rs 4.0244. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Saroja Pharma Inds. in Ticker for free. Also, one can get the intrinsic value of Saroja Pharma Inds. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Saroja Pharma Inds. FAQs

Q1. What is Saroja Pharma Inds. share price today?
Ans: The current share price of Saroja Pharma Inds. is Rs 31.35.

Q2. What is the market capitalisation of Saroja Pharma Inds.?
Ans: Saroja Pharma Inds. has a market capitalisation of Rs 12.60422361 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Saroja Pharma Inds.?
Ans: The PE ratio of Saroja Pharma Inds. is 7.7899811151973 and the P/B ratio of Saroja Pharma Inds. is 0.804062632247144, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Saroja Pharma Inds. share?
Ans: The 52-week high share price of Saroja Pharma Inds. is Rs 60, and the 52-week low share price of Saroja Pharma Inds. is Rs 28.

Q5. Does Saroja Pharma Inds. pay dividends?
Ans: Currently, Saroja Pharma Inds. does not pay dividends. Dividend yield of Saroja Pharma Inds. is around 0%.

Q6. What are the face value and book value of Saroja Pharma Inds. shares?
Ans: The face value of Saroja Pharma Inds. shares is Rs 10, while the book value per share of Saroja Pharma Inds. is around Rs 38.9895. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Saroja Pharma Inds.?
Ans: Saroja Pharma Inds. has a total debt of Rs 9.4563 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Saroja Pharma Inds.?
Ans: The ROE of Saroja Pharma Inds. is 6.8225% and ROCE of Saroja Pharma Inds. is 12.5647%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Saroja Pharma Inds. a good buy for the long term?
Ans: The Saroja Pharma Inds. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Saroja Pharma Inds. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Saroja Pharma Inds. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Saroja Pharma Inds.’s financials?
Ans: You can review Saroja Pharma Inds.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.